Tempest Therapeutics, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions
Tempest Therapeutics, Inc. (TPST) had Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions of 4 security as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Number of Positions
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions · last filed 2018-11-09
- 2018-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions 4.00 security.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions |
|---|---|
| 2018-09-30 | 4.00 security 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |